scholarly article | Q13442814 |
P50 | author | Yin C Lin | Q55458944 |
Elise Murat | Q95953253 | ||
P2093 | author name string | Yong-Jun Liu | |
Virginia Pascual | |||
HyeMee Joo | |||
Seunghee Hong | |||
Tae Whan Kim | |||
Taeil Kim | |||
P2860 | cites work | A Toll-like receptor recognizes bacterial DNA | Q24290668 |
ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses | Q24295036 | ||
Antiviral activities of ISG20 in positive-strand RNA virus infections | Q24305035 | ||
Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
Myc represses transcription through recruitment of DNA methyltransferase corepressor | Q24557458 | ||
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities | Q24617969 | ||
Immunomodulatory functions of type I interferons | Q26823904 | ||
c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation | Q28115670 | ||
Long non-coding RNAs: insights into functions | Q28131764 | ||
c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function | Q28143677 | ||
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway | Q28190704 | ||
BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells | Q28286641 | ||
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients | Q28290930 | ||
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA | Q28513215 | ||
Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo | Q28609049 | ||
The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3 | Q28609763 | ||
Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators | Q28703540 | ||
Type I interferons in host defense | Q29615912 | ||
The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 | ||
A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein | Q31988206 | ||
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation | Q33667278 | ||
c-Myc target genes involved in cell growth, apoptosis, and metabolism | Q33956988 | ||
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy | Q33973488 | ||
A conserved element in Myc that negatively regulates its proapoptotic activity | Q34166620 | ||
Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells | Q34209662 | ||
Amplification of oncogenes revisited: from expression profiling to clinical application | Q34258395 | ||
MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells | Q44224972 | ||
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. | Q52582850 | ||
Myc-mediated transcriptional repression by recruitment of histone deacetylase. | Q53477081 | ||
Translational control of the innate immune response through IRF-7 | Q57203299 | ||
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape | Q57272360 | ||
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon | Q57275922 | ||
c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation | Q74541449 | ||
A new mode of transcriptional repression by c-myc: methylation | Q81232076 | ||
Interferons alpha and beta as immune regulators--a new look | Q34289965 | ||
Chromosome-mediated alterations of the MYC gene in human cancer. | Q34778071 | ||
A long noncoding RNA connects c-Myc to tumor metabolism. | Q34830610 | ||
IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts | Q35122228 | ||
Regulation of IRF7 through cell type-specific protein stability | Q35148066 | ||
Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis | Q35675517 | ||
Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression | Q35774136 | ||
Dcp2 decapping protein modulates mRNA stability of the critical interferon regulatory factor (IRF) IRF-7. | Q35806638 | ||
The host type I interferon response to viral and bacterial infections | Q36178864 | ||
Long non-coding RNAs and cancer: a new frontier of translational research? | Q36208103 | ||
Transcriptional regulation and transformation by Myc proteins | Q36215755 | ||
Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA. | Q36232223 | ||
The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection | Q36402648 | ||
A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses | Q36567669 | ||
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo | Q36589100 | ||
Cancer risk in systemic lupus: an updated international multi-centre cohort study | Q36823763 | ||
The interferon-α signature of systemic lupus erythematosus | Q36856706 | ||
Interferon regulatory factor family of transcription factors and regulation of oncogenesis | Q37055295 | ||
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. | Q37222231 | ||
Sin3 corepressor function in Myc-induced transcription and transformation | Q37409356 | ||
Deconstructing repression: evolving models of co-repressor action | Q37677559 | ||
Interferon-stimulated gene 15 and the protein ISGylation system | Q37824472 | ||
Interferon: a decade of accomplishments, foundations of the future in research and therapy | Q38165443 | ||
Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides | Q38289912 | ||
Activation of the transcription factor ISGF3 by interferon-gamma | Q38322204 | ||
Sequence-specific DNA binding by the c-Myc protein | Q38338266 | ||
OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. | Q39193091 | ||
The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor | Q39791268 | ||
C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma | Q40185161 | ||
Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. | Q40338330 | ||
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. | Q40424280 | ||
Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction | Q40437839 | ||
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction | Q40446857 | ||
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer. | Q40674553 | ||
Ras enhances Myc protein stability. | Q40967066 | ||
Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells | Q41477085 | ||
Rheumatoid arthritis induced by alpha-interferon therapy | Q41918975 | ||
The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone. | Q41953880 | ||
Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour | Q42099573 | ||
E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination | Q42814364 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 3348-3359 | |
P577 | publication date | 2016-09-14 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic Cells | |
P478 | volume | 197 |
Q39071091 | Absent in Melanoma 2 proteins in SLE. |
Q44717067 | Alterations of oncogenes expression in NK cells in patients with cancer |
Q43930865 | Disease-Associated Plasmacytoid Dendritic Cells |
Q92632393 | Fimbriae reprogram host gene expression - Divergent effects of P and type 1 fimbriae |
Q92014001 | Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models |
Q37624648 | Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India |
Q97559063 | NCoR1 fine-tunes type-I IFN response in cDC1 dendritic cells by directly regulating Myd88-IRF7 axis under TLR9 |
Q41994684 | O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection. |
Q54121472 | The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells. |
Q40068214 | The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus |
Search more.